Sort
17,828 grants matching “crispr”
RNAi Screening in Hematopoietic Cells
$554,213Iain Fraser · National Institute Of Allergy And Infectious Diseases · ZIA · FY2016 · AI
The Investigation of disease causing genes in C. elegans
$553,987Andy Golden · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2015 · DK
Metabolomics of cGVHD
$553,947Bruce R. Blazar · Dana-Farber Cancer Inst · P01 · FY2024 · HL
Project 4: Transcriptional Coactivators and Enhancers in Human Cancer
$553,842Christopher Vakoc · Cold Spring Harbor Laboratory · P01 · FY2018 · CA
Advancing immune organoid technology and organoid combinations
$553,826Mark M Davis · Stanford University · U19 · FY2024 · AI
Project 1. Gene Variants and Their Interactions Defining Human NTD Risk
$553,582Margaret Elizabeth Ross · Weill Medical Coll Of Cornell Univ · P01 · FY2020 · HD
Combinatorial regulation of the enhancer codes in senescence
$553,553Michael G Rosenfeld · University Of California, San Diego · R01 · FY2020 · AG
The role of AU-rich element binding proteins in shaping target mRNA expression
$553,531Markus Hafner · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2021 · AR
Causal variant association mechanisms in TCF21 binding coronary disease loci
$553,417Thomas None Quertermous · Stanford University · R01 · FY2024 · HL
Multi-omic phenotyping of human transcriptional regulators
$553,390Brian S White · Jackson Laboratory · U01 · FY2024 · HG
Metabolic barriers to T cell activation in clear cell renal cell carcinoma
$553,322Jeffrey C Rathmell · Vanderbilt University Medical Center · R01 · FY2023 · CA
Defining cellular states of quiescence in human brain tumors
$553,130Patrick Paddison · Fred Hutchinson Cancer Research Center · R01 · FY2021 · NS
A Psilocybin-Sensitive Neuroimmune Circuit Controlling Stress Behaviors
$553,029Michael Alex Wheeler · Brigham And Women'S Hospital · R01 · FY2025 · DA
A Psilocybin-Sensitive Neuroimmune Circuit Controlling Stress Behaviors
$553,029Michael Alex Wheeler · Brigham And Women'S Hospital · R01 · FY2024 · DA
Project 2: Why are mucins so gigantic and is it safe/effective to sever them therapeutically?
$552,963Richard C Boucher · Univ Of North Carolina Chapel Hill · P01 · FY2022 · HL
Project 2: Why are mucins so gigantic and is it safe/effective to sever them therapeutically?
$552,963Richard C Boucher · Univ Of North Carolina Chapel Hill · P01 · FY2023 · HL
CRSIPR screening for novel regulators of retinal ganglion cell survival and axonal regeneration
$552,932Zhigang He · Boston Children'S Hospital · R01 · FY2019 · EY
Discovery of Somatic Noncoding Variants that Serve as Drivers in Pediatric Cancers
$552,832Jinghui Zhang · St. Jude Children'S Research Hospital · R01 · FY2022 · CA
Zfp423 Mechanisms in Joubert Syndrome and Related Disorders
$552,736Bruce A Hamilton · University Of California, San Diego · R01 · FY2022 · NS
LNCRNA REGULATION OF GENE EXPRESSION & BEHAVIOR
$552,717Sean P Farris · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · AA
LNCRNA REGULATION OF GENE EXPRESSION & BEHAVIOR
$552,717Sean P Farris · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · AA
LNCRNA REGULATION OF GENE EXPRESSION & BEHAVIOR
$552,717Sean P Farris · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · AA
LNCRNA REGULATION OF GENE EXPRESSION & BEHAVIOR
$552,717Sean P Farris · University Of Pittsburgh At Pittsburgh · R01 · FY2022 · AA
Understanding druggable drivers of meningioma tumorigenesis
$552,640David R Raleigh · University Of California, San Francisco · R01 · FY2023 · CA
Development of novel protein-based therapeutics for lung cancer
$552,581Eric Alejandro Sweet-Cordero · University Of California, San Francisco · R01 · FY2022 · CA